TVM Life Science Management GmbH

PRESS RELEASE

published on 02/06/2024 at 10:10, 1 year 11 months ago

TVM CAPITAL LIFE SCIENCE CO-LEADS $16 MILLION SERIES A FINANCING ROUND FOR VEKTOR MEDICAL TO REVOLUTIONIZE ARRHYTHMIA CARE
TVM CAPITAL LIFE SCIENCE CO-LEADS $16 MILLION SERIES A FINANCING ROUND FOR VEKTOR MEDICAL TO REVOLUTIONIZE ARRHYTHMIA CARE. TVM Capital Life Science announces a $16 million Series A financing for Vektor Medical, a pioneer in non-invasive, AI-based arrhythmia analysis technology

Series A Financing TVM Capital Life Science Vektor Medical Arrhythmia Care AI-based Analysis
PRESS RELEASE

published on 01/31/2024 at 10:00, 2 years ago

TVM CAPITAL LIFE SCIENCE ANNOUNCES €8 MILLION INVESTMENT IN MYO TO REVOLUTIONIZE ELDERLY CARE VIA INNOVATIVE, EASY-TO-USE APP
TVM Capital Life Science invests €8 million in Myosotis GmbH to revolutionize elderly care with innovative app, strengthening healthcare communication and administrative processes in care homes

Investment TVM Capital Life Science Myosotis GmbH Innovative App Elderly Care
PRESS RELEASE

published on 07/20/2023 at 14:00, 2 years 6 months ago

Tillotts Pharma and TVM Capital Life Science Announce Formation of Mage Biologics to Develop Innovative Oral Antibody Therapy for Ulcerative Colitis
PRESS RELEASE

published on 03/17/2023 at 14:00, 2 years 10 months ago

TVM Capital Life Science to participate in LSI USA ’23 Emerging Medtech Summit 2023
PRESS RELEASE

published on 02/23/2023 at 14:00, 2 years 11 months ago

TVM Capital Life Science Announces Promotions to Recognize Significant Contributions of Up-and-Coming Leaders
PRESS RELEASE

published on 02/08/2023 at 14:00, 2 years 11 months ago

TVM Capital Life Science Announces Creation of LAmAb Biologics to Develop Innovative Preventative Therapy for Allergy Patients
PRESS RELEASE

published on 02/01/2023 at 14:00, 3 years ago

TVM Capital Life Science announces up to USD 24 million investment in oncology company, Recurv Pharma, Inc.

Published on 02/06/2026 at 00:57, 1 hour 57 minutes ago

Noram Lithium Announces Closing of Fully Allocated Non-Brokered Financing
Published on 02/06/2026 at 00:00, 2 hours 54 minutes ago

LIR Life Sciences Commences Project Phase 2 Peptide Design Program with Neuland Laboratories
Published on 02/05/2026 at 23:15, 3 hours 39 minutes ago

Amarc Further Expands Its Toodoggone Technical Team
Published on 02/05/2026 at 23:00, 3 hours 54 minutes ago

Grounded People Announces Non-Brokered Private Placement and Strategic Review
Published on 02/05/2026 at 21:00, 5 hours 54 minutes ago

Kidoz Welcomes CloudX Innovation Driving Fairer Mobile Advertising Auctions

View all ACCESSWIRE

Published on 02/05/2026 at 19:27, 7 hours 26 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/05/2026 at 18:46, 8 hours 7 minutes ago

EQS-Adhoc: Mayr-Melnhof Karton AG: Impairment requirements impact profit for the financial year 2025
Published on 02/05/2026 at 18:09, 8 hours 44 minutes ago

Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/05/2026 at 17:55, 8 hours 58 minutes ago

Piramal Critical Care and Blue-Zone Technologies collaborate to capture, collect and recycle waste anaesthesia gas
Published on 02/05/2026 at 17:05, 9 hours 48 minutes ago

European Research and Innovation: the Politecnico di Milano Launches an Office in Brussels

View all EQS

Published on 02/05/2026 at 19:24, 7 hours 29 minutes ago

Minutes of the Combined General Meeting
Published on 02/05/2026 at 18:24, 8 hours 29 minutes ago

LNA SANTE : 2025 annual sales
Published on 02/05/2026 at 18:06, 8 hours 47 minutes ago

Aéroports de Paris SA - Shares and voting rights as of 31 January 2026
Published on 02/05/2026 at 18:00, 8 hours 54 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of January 30, 2026
Published on 02/05/2026 at 18:00, 8 hours 54 minutes ago

ACM - Press release 2025 results

View all LES ECHOS COMFI WIRE

News